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Abstract
Objective—To describe the array of sexual health care services provided at US colleges and 
universities.
Participants—During 2014–2015, 885 colleges were surveyed about their provision of sexual 
health services.
Methods—55% of colleges responded. Data were weighted and stratified by minority-serving 
institutions (MSIs), 2-year and 4-year institutions.
Results—70.6% of colleges reported having a health center (HC), of which 73.0% offered STI 
diagnosis/treatment (4 years vs. 2 years; 77.9% vs. 53.1%) and contraceptive services (70.1% vs. 
46.4%), all p < .001. HCs less frequently offered LARC (19.7%), express STI testing (24.4%) and 
self-collection (31.4%). Condoms were available on 66.8% of campuses. HPV vaccination was 
available at more 4-year colleges (73.7% vs. 48.5%, p < .003) and non-MSIs (74.4% vs. 58.5, p = .
019). Regarding MSM-targeted services, 54.6% offered pharyngeal and 51.8% rectal STI testing.
Conclusions—2-year colleges may require additional support with providing sexual health care. 
Improvements could entail increasing express testing, extra-genital STI testing, and LARC.
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Each year there are approximately 20 million new sexually transmitted infections (STIs) in 
the United States (US).1 Adolescents and young adults aged 15–24 remain 
disproportionately affected by STIs, with an estimated 50% of new infections occurring 
within these populations.1 In 2014, 15–24 year olds accounted for the majority of reported 
gonorrhea and chlamydia cases, 53% and 66%, respectively.2 A recent study suggests that 
chlamydial infection among college students may be higher than the estimated prevalence of 
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chlamydia in the general population (6.5% vs. 4.7%), and that chlamydia positivity may be 
higher on 4-year campuses and at minority serving institutes (10.0% vs. 5.4%) (MSIs: eg, 
Historically Black Colleges and Universities (HBCU), Tribal College or University (TCUs)).
3
Of the over 30 million 18–24 year olds in the United States, approximately 43% are 
currently enrolled in an institution of higher education4 of which there are nearly 4,500 
degree-granting institutions.5 These institutions comprise a mix of public and private 
institutions, technical schools, community colleges, traditional 4-year colleges, and large 
research universities.5 Young adulthood is the peak age group for many risk behaviors, 
including binge drinking, multiple sex partners, unprotected sex, and unintended pregnancy. 
College students report engaging in these behaviors, putting them at risk for STI acquisition 
and transmission.3,6
The US Preventative Services Task Force (USPSTF) recommends sexually active women 
aged 24 and younger be screened annually for chlamydia and gonorrhea.7 Other key 
recommendations for sexual health8 among college populations include HIV testing, STI 
screening for men who have sex with men (MSM), and HPV vaccination.9,10,11 College 
health centers (HCs) can play a pivotal role in the delivery of recommended services as well 
as in normalizing sexual health as part of one’s overall well-being.
The number of colleges and universities with a designated HC, or that in some way provide 
sexual health care services to their students, is not regularly assessed by any entity. The 
American College Health Association’s (ACHA) annual survey collects self-reported data 
on the availability of screening for STIs in college HCs12; however, survey respondents are 
self-selected, with a bias towards participation from schools with strong data collection 
systems, thus the findings are not representative of college HCs across the United States. 
The last national study of STI service provision in US colleges and universities (including 2- 
and 4-year institutions, but not MSIs) was conducted in 2001 and found that 60% of schools 
had a HC,13 and of these, 66% provided STI services. In a national assessment of sexual 
health services on community college campuses, conducted in 2000, 42% of responding 
colleges reported having a HC, of which 15% and 25% offered HIV and STI testing on 
campus, respectively. Almost all schools made referrals to outside organizations, and 21% 
reported testing services were funded by a health department.14 These studies were 
conducted more than a decade ago and with college enrollment increasing 37% from 2000 to 
2010,15 an update to assess if US colleges and universities have improved and maintained 
their capacity to offer important health services to students is warranted.
Furthermore, differences in available sexual and reproductive health care services by MSI 
designation have not been explored. Depending on geographic location, MSIs and 2-year 
colleges may serve a disproportionate number of students from low socio-economic 
backgrounds with students who are uninsured or underinsured or are Medicaid eligible.3,16 
Although behavioral risk factors for HIV/STI transmission can be prevalent among college 
students in general,6 students enrolled at MSIs and 2-year schools may face additional 
challenges (eg, greater risk of disease transmission during new sexual encounters due to 
sexual partner networks, limited access to quality healthcare and prevention education).17,18 
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Little is known about how MSIs and 2-year colleges provide sexual health care or handle 
referrals into the community when services are unavailable on campus. Hence, the need to 
explore the availability of sexual health care services on these overlooked campuses.
This study aims to describe the current state of sexual health care services provided at US 
colleges and universities by: (1) estimating the proportion of 2- and 4-year colleges and 
MSIs that have a student health or wellness center on campus, including the proportions of 
these schools that provide access to STI education, prevention, and treatment services, and 
(2) assessing the level of interest, among all the schools sampled, in partnering with 
community health centers (CHCs) and federally qualified health centers (FQHCs).
Methods
We conducted a nationally representative web-based survey of US colleges and universities 
adapted from previous work conducted by Koumans et al13 while adding some new items of 
interest. The survey measured requirements for health insurance coverage, health care fees, 
availability of health care services on campus or linkage to care elsewhere, and student HC 
offerings, including: preventative services, STI/HIV prevention, education, screening, testing 
and treatment, contraceptive and condom availability, patient-delivered partner therapy, HPV 
vaccination, confidentiality/privacy assurances, community referrals, and interest in 
technical assistance from community partners. In-depth findings related to patient-delivered 
partner therapy, insurance coverage, health care fees, and confidentiality assurances are 
beyond the scope of this work. The survey was piloted by three seasoned health care 
providers: one from a 4-year college, one from a 2-year college, and the third from an MSI.
Eligible respondents were identified in the Integrated Postsecondary Education Data System 
(IPEDS),19 using 2011 enrollment data. Active, 2- or 4-year, degree granting, accredited 
public or private schools that enrolled at least 500 undergraduates and/or graduate students 
in the US were included, yielding a sampling frame of 2,753 schools. The sampling frame 
was then stratified by MSIs and enrollment size of the school. Minority-serving institutes 
were classified based on federal definitions.20 Enrollment size of the school was categorized 
as 500–1,000 students, 1,001–2,000 students, 2,001–4,000 students, 4,001–8,000 students, 
8,001–16,000 students, and >16,001 students. To obtain statistically robust sample sizes for 
schools with and without student health centers, we oversampled schools with small 
numbers of students as well as large numbers of students. Schools that have small 
enrollment numbers are less likely to have student health centers and schools with large 
enrollment are more likely to have health centers Schools within each strata of enrollment 
size and significant minority enrollment were sampled randomly with equal probability.
A stratified random sample of 885 schools was sent an introductory letter and questionnaire. 
The letter noted that the questionnaire should be completed by the individual most 
knowledgeable about health services on campus. After agreeing to participate, respondents 
were prompted to complete a self-administered electronic questionnaire via SurveyMonkey. 
During the data collection period (July 14, 2014–May 31, 2015), schools were periodically 
sent reminder emails or phone calls.
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Analyses assessed differences between responding and non-responding schools and no 
significant response bias was noted. A comprehensive weight was calculated and applied to 
the dataset, which was based on school characteristics listed in IPEDS including institution 
type (2-year, 4-year), funding type (private, public), enrollment size, and region (South, 
West, Northeast, Midwest). All analyses were conducted using complex survey analysis 
procedures in SPSS version 21.0 (SPSS, Inc., Armonk, NY) and SAS 9.3 (SAS Inc., Cary, 
NC). Chi-square tests were conducted to compare weighted proportions, with statistical 
significance set at p < .05. The study protocol and survey were approved by an institutional 
review board of the Centers for Disease Control and Prevention.
Results
College characteristics
Of the 885 institutions contacted, 482 (54.5%) completed the survey. Of those, 11% had 
more than 16,000 students, 65% were 4-year institutions, and a quarter (25.8%) were MSIs. 
In addition, 58.5% were public, 35% were located in the South, and the majority (70.6%) 
reported having a health or wellness center on campus. More information on college 
characteristics is presented in Table 1.
Characteristics of student health centers
Institutions with student HCs differed in the way they operated and offered services to 
students based on institution type and MSI designation (Table 2). For example, compared to 
2-year colleges, 4-year colleges offered more online booking of appointments (21.7% vs. 
5.6%, p < .001) and the option of contacting a health care provider online (43.6% vs. 17.1%, 
p < .001). Nearly half of MSIs (47.0%) offered evening clinic hours compared to 30.8% of 
non-MSIs (p < .01), but more non-MSIs offered more weekend clinic hours (16.9% vs. 
4.2%, p < .001) and availability of health care providers via online portal (42.0% vs. 28.0%, 
p = .035).
Differences were also revealed in the administration of the student HCs (all p < .001). 
Overall, HCs reported being primarily run by nurses (33.4%) and nurse practitioners 
(22.3%). This was also observed among 2-year and 4-year schools, and MSIs and non-MSIs. 
However, there were more instances where 4-year schools’ HCs were more likely to be run 
by physicians (17.7%) and physician’s assistants (3.6%) than 2-year schools (1.3% and 
1.3%, respectively) and more MSIs reported instances of a health care administrator running 
the HCs (14.3%) compared to non-MSIs (9.5%), 2-year (4.7%), and 4-year institutions 
(12.2%).
Health insurance requirements & fees
Of the total sample, 37.2% required mandatory insurance coverage, however, it was more 
frequently a requirement among 4-year schools compared to 2-year (50.6% vs. 10.5%, p < .
001) and for non-MSIs compared to MSIs (42.3% vs. 23.4%, p < 001). Nearly half (47.8%) 
of surveyed colleges reported having a student health fee; 58.5% of 4-year schools compared 
to 28.0% of 2-year (p < .001). Insurance coverage for STI screening was higher in 4-year 
schools versus 2-year (89.2% vs. 63.8%, p < .01) and in non-MSIs versus MSIs (88.9% vs.
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79.8% p = .03). When asked to describe how the cost of STI screening is covered at their 
health center, most respondents (41.5%) reported that all tests/visits to the HC were charged 
directly to the patient or to their health insurance or they reported that some tests/visits are 
charged for, but others are free (36.4%); 10.2% reported tests/visits were free to students. 
Finally, 39.3% of the institutions reported that they were aware of students who sought STI 
services at an off-site location to avoid high deductibles or co-pays; an almost equal amount 
said they were not aware of any patients seeking services elsewhere (36.9%) (data not shown 
in tables).
STI education/promotion & condom availability
Among the total sample, written sources (eg, flyers, pamphlets, newsletters) were the most 
common STI health promotion methods used by colleges (75.0%), followed by one-on-one 
education in HCs (66.1%), and health fairs (63.3%). Other common methods were posters 
(53.4%), lectures (47.6%), awareness/testing campaigns (49.8%), and testing events 
(39.1%). Four-year colleges reported a higher frequency of health promotion activities 
compared to 2-year (p < .001). Health fairs (73.0% vs. 59.8%, p < .01), and testing events 
(52.4% vs. 34.2%, p < .001) were higher among MSIs compared to non-MSIs. Condoms 
were available to students at 66.8% of colleges surveyed; 44.6% reported that they were on 
display for free (51.9% of 4-years vs. 30.6% of 2-years, p< .001) and were more likely to be 
available in 4-year HCs than 2-year (61.8% vs. 28.6, p < .001). Approximately 32% of 
schools surveyed did not make condoms available on campus (data not shown in tables).
Sexual health and contraceptive service offerings
Most colleges (91.0%) with a HC offered at least one sexual health service. Overall, 73.0% 
of colleges were able to diagnose and treat STIs. Four-year institutions reported higher STI 
diagnosis and treatment services than 2-year (77.9% vs. 53.1%, p < .001), emergency 
contraceptives (EC) (53.6% vs. 40.5%, p < .05), and long-acting reversible contraceptives 
(LARC, 22.7% vs. 7.3%, p < .01) showed the largest proportional differences. Few 
differences emerged between MSIs and non-MSIs (see Table 2 for the full list of services).
STI services—Table 3 displays the scope of STI screening/testing services available to 
students at their institution’s HC. Overall, (88.5%) offered screening/testing for STIs; HIV 
testing was available at almost all colleges (92.4%). Four-year schools had higher 
availability of STI screening/testing services compared to 2-year (91.9% vs. 71.0%, p < .
001). Almost three-quarters of HCs (73.8%) routinely screened women under 25 years old 
for chlamydia and offered follow-up testing (82.9%). Less frequently offered services 
included express testing (24.4%) and self-collected vaginal swabs (SCVS) (31.4%). No 
statistical differences emerged between institutions for these services.
MSM services—Some HCs also reported having extragenital screening such as rectal 
(51.8%) and pharyngeal (54.6%) STI testing targeted at MSM. Availability of rectal testing 
services for gonorrhea and chlamydia was 52.5% for 4-year schools and 46.5% for 2-year, 
50.2% for MSIs and 52.3% for non-MSIs. Pharyngeal testing was available at 54.4% of 4-
year and 54.2% of 2-year schools, similar to the availability among MSIs and non-MSIs 
(54.7% and 54.6%, respectively). A quarter of schools reported not knowing if pharyngeal or 
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rectal testing for chlamydia and gonorrhea was offered to MSM students. No statistically 
significant differences between institutions emerged regarding the availability of these 
services (data not shown in tables).
HPV immunization—The HPV vaccine was available in 70.5% of HCs; of those, 75.5% 
covered the vaccine under their student health insurance plan, and almost all institutions 
offered the vaccine to both males and females (98.3%). The HPV vaccine series was 
available at significantly more 4-year schools than 2-year (73.7% vs. 48.5%, p < .01). 
Among colleges offering the vaccine, a higher proportion of 4-year schools offered 
reminders for the second and third dose than 2-year (64.0% vs. 23.0%, p < .001). More 4-
year schools offered HPV vaccine to MSM (92.6% vs. 76.4%, p < .05) than 2-year. 
Compared to MSIs, HPV vaccination was offered by more non-MSIs (74.4% vs. 58.5, p = .
019) (data not shown in tables).
Referrals, community support, and partnerships
Almost all colleges had a referral mechanism in place (90.5%) and 80.3% were interested in 
improving their referrals (Table 4). Compared to 2-year colleges, 4-year colleges referred 
sexual health cases more often to private doctor’s offices (55.0% vs. 30.7%, p < .001) and to 
family planning clinics (40.6% vs. 30.2, p < .05). However, 2-year most often referred to 
CHCs (42.7% vs. 29.4%, p < .01). Compared to non-MSIs, MSIs reported having a referral 
mechanism less often (93.2% vs. 83.4%, p < .01), but non-MSIs more frequently reported 
referring to private doctor’s offices as compared to MSIs (50.4% vs. 36.5%, p = .01). 
Interestingly, all colleges referred approximately 30% of STI patients to urgent care clinics.
Most colleges received some support from their health department with regard to STI/HIV 
screening and testing, however, a third did not. Over three quarters of the sample were 
interested in partnering with FQHCs or CHCs; there was a higher proportion of interest in 
these partnerships among 2-year colleges and MSIs. Overall, almost 60% of schools 
reported that HCs were the primary source of STI services on their campus, followed by 
local organizations (21.3%) and public health departments (18.9%)
Comment
This study provides an overview of sexual and reproductive health services available among 
a nationally representative sample of US colleges and universities, including 2-year 
institutions and MSIs. We found that 70.6% of colleges reported having a student HC, of 
which almost three-quarters offered STI diagnosis and treatment. This is a 10% increase 
from the 2001 Koumans study13 which found that 60% of schools had a HC, of which 62% 
provided testing for the most common STIs. Likewise, the offering of contraceptive services 
(65.4% vs. 54.0%) may have increased among college HCs, with EC and LARC now 
available at 51% and 20% of health centers (though provision of both EC and LARC could 
be more routine).
Health education and promotion is high on college campuses (95.6%). Flyers, pamphlets, 
and posters continue to be common ways to raise awareness of sexual health along with one-
on-one peer education methods. However, other peer education modalities besides one-on-
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one education may be useful for increasing awareness and should be explored. Koumans 
suggested that the health education efforts on campuses were not robust enough to impact 
behavior change.13 We added a question about whether schools had an STI awareness or 
testing campaign, and almost half reported offering that type of health promotion activity, 
which has been associated with increases in STI and HIV testing.21,22 We also found that 
condoms were more readily available compared to 2001 (66.8% vs. 52.0%). Condoms 
remain a key STI prevention strategy and are highly effective in preventing STIs and HIV 
when used consistently and correctly.23 However, a third of schools in this study did not 
make condoms available to students on campus.
Four-year and non-MSI HCs were better at offering flexible hours and technologically 
advanced health services to their students. Research suggests that STI patients value flexible 
clinic hours,24 electronic appointment scheduling, and opportunities for electronic 
communication with the health center.25 Structural or systems changes such as these could 
increase students’ access to sexual and reproductive services on campus.
Few differences emerged regarding STI/HIV screening and service offerings between 2- and 
4- year colleges with the exceptions that 4-year colleges more frequently reported being able 
to diagnose and treat STIs and routinely screened asymptomatic students for STIs compared 
to 2-year. Overall, most HCs routinely screened women under 25 years for chlamydia 
(73.8%) suggesting that college health professionals do a good job screening female 
students, but there is still room for improvement. Express testing and SCVS were only 
offered by a quarter and a third of HCs. University health settings are an ideal location for 
innovative testing methods such as SCVS, which are cost effective, more sensitive than 
urine, and easier to process/transport than traditional clinician-obtained specimens.26 
Additionally, chlamydia/gonorrhea positivity may be higher among asymptomatic self-
testers compared to clinician-collected testers, as was found in an evaluation of self-testing/
SCVS program in one university setting.27 Few signigicant differences in services existed 
between MSIs and non-MSIs; however, MSIs less frequently offered HPV vaccination 
compared to non-MSIs. College HCs have the ability to play an important role in cervical 
cancer prevention by providing catch-up HPV vaccination. National data and research 
suggest that initiation and completion rates of HPV vaccine among black and Hispanic 
adolescents and college women are lower than their racial and ethnic counterparts.28,29 
Given that cervical cancer is more common among Hispanic and black women,30 MSI HCs 
especially, may want to explore ways to promote and/or offer affordable HPV vaccination on 
campus.
Young gay, bisexual, or other men who have sex with men (YGBMSM) are at increased risk 
for STIs and HIV, especially YGBMSM of color.31 The STD Treatment Guidelines 
recommend that clinicians routinely ask MSM about symptoms consistent with common 
STIs and offer evidence-based counseling on safer sex.11 Rectal and pharyngeal STI tests 
are recommended for sexually active MSM who have had receptive anal and oral sex during 
the preceding year.11 However, less than half of the schools we surveyed offered pharyngeal 
and rectal STI testing, and a quarter reported not knowing if extra-genital testing was 
available. College health providers may require more training and guidance around extra-
genital screening and assessing a patient’s sexual risk.
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Finally, free STI testing was offered by only 10.3% of HCs, and a substantial portion of 
schools reported that students sought STI services elsewhere to avoid high-deductibles and 
co-pays. Some colleges have addressed this challenge by incorporating the cost of STI 
testing into student health fees, however less than 40% of the colleges surveyed had such a 
policy. HCs may also want to consider partnering with local CBOs or health departments to 
support STI/HIV testing on campus.32 Over a third of colleges reported that a local health 
department or outside organization were the primary offerors of STI services on their 
campus; however, the same percentage reported that they received no such support from 
their local health department. Most schools were interested in learning more about how to 
strengthen partnerships with FQHCs and CHCs to support STI/HIV testing on campus. 
Health departments, CHCs, and FQHCs could consider expanding outreach or linkage to 
care to colleges and universities in high morbidity areas. Partnerships focused on increasing 
student access to sexual health services could be especially beneficial to 2-year colleges and 
MSIs where some enrolled students might be Medicaid eligible.
Limitations
These data are cross-sectional and only provide a snap shot of the sexual and reproductive 
health care services being offered on US college campuses. Likewise, the quality of the data 
is dependent on the knowledge of health services of the person completing the survey which 
may vary by school, but nearly all respondents identified themselves as a director or medical 
professional connected to health services. Comparisons to the Koumans study should be 
interpreted with caution as we did not survey the same set of colleges and universities. Our 
study did not assess the full range of reproductive services available to students, nor did it 
assess the provision of abortion services and/or referrals, but future assessments may want 
to. We also did not collect data on STI morbidity at the colleges surveyed, which may have 
provided additional insight into the quality of services offered.
Conclusions
This study updates the literature on the state of sexual health services available among a 
nationally representative sample of US colleges and universities. Colleges with HCs are 
providing a variety of sexual health services, including STI/HIV education, and few 
significant differences in STI service offerings exist between 4- and 2-year colleges and 
MSIs compared to non-MSIs. Generally, colleges are providing STI/HIV education and 
screening (including asymptomatic students) at high frequencies. Improvements could entail 
increasing extragenital STI testing for MSM, increasing the provision of LARC and EC, 
removing barriers to testing by offering self-testing,26,27 offering e-communication with 
providers through patient portals, and expanding clinic hours.24,25 Simple strategies such as 
enhanced training of health care staff may help increase the provision of LARC and 
extragenital STI testing. Additionally, MSIs might consider boosting HPV vaccination 
efforts. These data suggest there is interest in receiving support from health departments and 
in partnerships with CHCs and FQHCs; 2-year colleges may especially benefit from entering 
into such partnerships. Further research is needed to explore barriers to offering STI services 
on 2-year campuses and gauge health care expectations of students, as well as the individual 
Habel et al. Page 8
J Am Coll Health. Author manuscript; available in PMC 2019 September 05.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
barriers students may face to access sexual health services on campus such as cost and 
insurance coverage.
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